Amos-1000

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameAmos-1000

Drug Alias NameN/A

ClassificationNatural product/Extract

Mechanisms of ActionCell division inhibitors

TargetsUpdating

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEnsol Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesEnsol Biosciences Inc

Active IndicationsN/A

Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A

Related LinksN/A